Image-Enhanced Endoscopy in the Gastrointestinal Tract
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT04085211|
Recruitment Status : Recruiting
First Posted : September 11, 2019
Last Update Posted : September 11, 2019
This study evaluates a range of endoscopic image enhancement techniques for assessing conditions involving the gastrointestinal tract.
This study aims to determine:
(i) the accuracy of different techniques to diagnose or grade severity of several gastrointestinal conditions
(ii) if image-enhancement techniques could potentially replace investigations currently used in daily practice (e.g. biopsy) with a view to reduce costs and shorten the interval to initiate treatment
|Condition or disease|
|Gastro-Intestinal Disorder Inflammatory Bowel Diseases Gastro Esophageal Reflux Atrophic Gastritis Neuroendocrine Tumors|
Endoscopic procedures are performed on a daily basis to visualise the gastrointestinal tract for diagnosis and intervention. The demand for procedures is growing, consequently increasing the number of additional investigations; for example, biopsies. Image enhancement techniques can be performed during procedures either digitally or through the use of dye. These techniques alter the qualities of the image e.g. colour, contrast and magnification. We believe these techniques have several potential benefits: (i) improve diagnostic accuracy (ii) filter appropriate selection of additional investigations to maximise diagnostic yield (iii) the potential to replace existing investigations which are costly and intricate.
Participants included in the study will have an endoscopic procedure as indicated for routine clinical care. On the day of the procedure (or before), a baseline assessment will be performed - symptom questionnaires, medical history and recording any relevant investigation results performed as part of routine care. Participants will have the endoscopic procedure as normal, with additional images and video obtained using different image enhancement techniques. Select patients will have follow-up for up to one year to determine relapse. The image enhancement technique findings will be compared to the gold standard investigation currently available as part of routine care for the condition of interest.
The study will look at a range of different image enhancement techniques: dye chromoendoscopy, blue laser imaging (BLI), linked colour imaging (LCI), narrow band imaging (NBI), image magnification and endocytoscopy. This will involve a range of gastrointestinal conditions.
Ethics Approval: favourable opinion was provided by the East Midlands - Derby research and ethics committee, reference: 19/EM/0167.
|Study Type :||Observational|
|Estimated Enrollment :||260 participants|
|Official Title:||A Series of Prospective Observational Studies Investigating the Clinical Utility of Image-enhanced Endoscopy in the Gastrointestinal (GI) Tract|
|Actual Study Start Date :||July 1, 2019|
|Estimated Primary Completion Date :||February 2022|
|Estimated Study Completion Date :||May 2022|
Inflammatory Bowel Disease
Patients with an established diagnosis of ulcerative colitis or Crohn's Disease who require either a flexible sigmoidoscopy or colonoscopy as part of routine care (e.g. surveillance or staging disease activity)
Patients with symptoms of gastro-oesophageal reflux disease
Patients with symptoms of gastro-oesophageal reflux disease requiring a gastroscopy as part of routine clinical care.
Patients with known or suspected atrophic gastritis that require a gastroscopy to either confirm the diagnosis or surveillance for pre-cancerous changes.
Patients with an established history of gastric neuroendocrine tumours requiring surveillance
- Sensitivity, specificity, positive predictive value of specific endoscopic image enhancement findings to diagnose or stage the severity of different gastrointestinal conditions [ Time Frame: 8 weeks ]Identify specific features on NBI,BLI, LCI, magnification and endocytoscopy to accurately diagnose / grade severity of a range of conditions when compared to the gold standard diagnostic investigation e.g. biopsy, pH impedance testing
- Specific image enhancement findings to predict relapse for patients with inactive inflammatory bowel disease. [ Time Frame: 12 months ]Relapse as defined by the requirement for treatment escalation, surgery, hospital admission; biochemical evidence of relapse (faecal calprotectin) or worsening inflammation on repeat endoscopy.
- median duration for image enhanced endoscopy procedures [ Time Frame: 1 day ]median duration (minutes) as defined as the time interval between insertion and completed withdrawal of the endoscope
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04085211
|Contact: Mehul Patel, MBBS, BScemail@example.com|
|Contact: Lee Meng Choong||02032991591||kch-tr.IBDtrials@nhs.net|
|Department of Gastroenterology, King's College Hospital||Recruiting|
|London, United Kingdom, SE5 9RS|
|Contact: Mehul Patel, MBBS 02032996044|
|Principal Investigator:||Bu'Hussain Hayee, PhD, MBBS,||King's College Hospital NHS Trust|